The FDA is expected to decide on treatments for familial chylomicronemia syndrome, type 1 diabetes, short bowel syndrome, and Prader-Willi syndrome.

The FDA is urging patients who have received drugs from Fullerton Wellness to stop using them and contact their health care provider.

Libby Baney, Senior Advisor to ASOP Global and a partner at Faegre Drinker Consulting, talks to MPR about the current state of online pharmacies and what is being done to protect patients.

Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.

Fewer patients experienced a first hospital admission for any indication and for serious adverse events while on semaglutide.

On a scale of 1 to 5 (1 being excellent and 5 being poor), those worried about the election had an average sleep quality of about 3.36 compared with 2.05 for those not affected by politics. About 18% ...

HealthDay News — Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can decrease the risk for developing early-onset colorectal cancer (EO-CRC) in patients with diabetes regardless of weight, ...

Coverage lower among health care personnel at nursing homes, while coverage for COVID-19 2023 to 24 vaccine was much lower.

Semaglutide linked to significantly reduced risk, most strongly compared with insulin and most weakly with other GLP-1 RAs.

Credit: Journey Medical Corporation. The approval was supported by data from 2 randomized, double-blind, active- and ...

(HealthDay News) — Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according to a ...

(HealthDay News) — Hormone replacement therapy (HRT) is associated with an increased risk for developing irritable bowel syndrome (IBS) in postmenopausal women, according to a study presented at the ...